|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2001-1-18
|
|
pubmed:abstractText |
To define the maximum-tolerated dose, recommended phase II dose (RD), dose-limiting toxicity (DLT), and pharmacokinetics of a novel taxane, RPR 109881A, administered on days 1 and 8 of a 21-day cycle.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BesenvalMM,
pubmed-author:D'AloisioSS,
pubmed-author:DaigneaultLL,
pubmed-author:EisenhauerEE,
pubmed-author:FisherBB,
pubmed-author:ForandDD,
pubmed-author:GénierLL,
pubmed-author:GelmonK AKA,
pubmed-author:LatreilleJJ,
pubmed-author:LebechJJ,
pubmed-author:TolcherAA,
pubmed-author:VernilletLL
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4098-108
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11118471-Adult,
pubmed-meshheading:11118471-Aged,
pubmed-meshheading:11118471-Agranulocytosis,
pubmed-meshheading:11118471-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:11118471-Diarrhea,
pubmed-meshheading:11118471-Dose-Response Relationship, Drug,
pubmed-meshheading:11118471-Drug Administration Schedule,
pubmed-meshheading:11118471-Female,
pubmed-meshheading:11118471-Humans,
pubmed-meshheading:11118471-Infusions, Intravenous,
pubmed-meshheading:11118471-Male,
pubmed-meshheading:11118471-Middle Aged,
pubmed-meshheading:11118471-Neoplasms,
pubmed-meshheading:11118471-Paclitaxel,
pubmed-meshheading:11118471-Taxoids
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.
|
|
pubmed:affiliation |
British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada. kgelmon@bccancer.bc.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|
